Abstract | BACKGROUND: PATIENTS AND METHODS: From September 1997 to March 1998, 23 chemo-naive patients of advanced gastric cancer were enrolled in this study. The regimen consisted of weekly 24-h infusion of 5-FU (2,600 mg/m2) and LV 150 mg and bimonthly cisplatin (25-50 mg/m2) bolus for 12 weeks followed by a 2-week break. RESULTS: There were 10 male and 13 female patients with a median age of 52 years. A total of 428 chemotherapy treatments were given with a mean of 11. Seventeen patients were evaluable for response. There were 41% (7/17) partial response, 18% (3/17) stable disease and 41% (7/17) progressive disease. The grade III or IV toxicity included anorexia 35% (8/23), fatigue 26% (6/23), vomiting 17% (4/23) and mucositis 9% (2/23). One patient developed perforated duodenal stump after chemotherapy. One patient died of hyperammonemia-related coma. The median times to disease progression and overall survival were 3.5 and 7 months, respectively. CONCLUSIONS: This regimen showed modest activity against gastric cancer. However, there was no survival advantage and there was greater toxicity than with weekly high-dose 5-FU-LV alone.
|
Authors | Y C Lin, J S Chen, C H Wang, H M Wang, H K Chang, C T Liaul, T S Yang, C C Liaw, H E Liu |
Journal | Japanese journal of clinical oncology
(Jpn J Clin Oncol)
Vol. 31
Issue 12
Pg. 605-9
(Dec 2001)
ISSN: 0368-2811 [Print] England |
PMID | 11902492
(Publication Type: Clinical Trial, Clinical Trial, Phase II, Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Cisplatin
- Leucovorin
- Fluorouracil
|
Topics |
- Adult
- Aged
- Antineoplastic Combined Chemotherapy Protocols
(administration & dosage)
- Cisplatin
(administration & dosage)
- Drug Administration Schedule
- Female
- Fluorouracil
(administration & dosage)
- Humans
- Leucovorin
(administration & dosage)
- Male
- Middle Aged
- Stomach Neoplasms
(drug therapy, mortality)
- Survival Rate
|